Hemic & Lymphatic

DC 7716

Aplastic anemia

Educational use only. Not legal or medical advice. Read 38 CFR §4.117 on eCFR
Diagnostic Code
7716
CFR Section
§4.117 — Hemic & Lymphatic

Rating Tiers

100%

Requiring peripheral blood or bone marrow stem cell transplant; or requiring transfusion of platelets or red cells, on average, at least once every six weeks per 12-month period; or infections recurring, on average, at least once every six weeks per 12-month period

60%

Requiring transfusion of platelets or red cells, on average, at least once every three months per 12-month period; or infections recurring, on average, at least once every three months per 12-month period; or using continuous therapy with immunosuppressive agent or newer platelet stimulating factors

30%

Requiring transfusion of platelets or red cells, on average, at least once per 12-month period; or infections recurring, on average, at least once per 12-month period

What Raters Look For

Based on M21-1 adjudication criteria for Hemic & Lymphatic conditions. These are the factors a VA rater evaluates when assigning a rating percentage.

M21-1 III.iv.4.G
  • •Complete blood count (CBC) values: hemoglobin, platelet count, white cell count
  • •Whether transfusions are required and how frequently
  • •Bone marrow biopsy or transplant history
  • •Response to treatment and current treatment regimen
  • •Constitutional symptoms: fatigue, weight loss, fever